Medford, Massachusetts, USA
February 25, 2014
GreenLight Biosciences and Bayer CropScience announced today a new partnership to explore applications of GreenLight’s proprietary cell-free technologies to increase the productivity of potential manufacturing processes. GreenLight’s assets can enable a new safe, fast, energy efficient and economical way of manufacturing crop protection products through bacteria which have been engineered to produce enzymes for cell-free chemical synthesis processes.
“At GreenLight Biosciences, we want to be at the forefront of creating new, non-petroleum based processes. Specifically we aim to replace the use of fossil hydrocarbons and expensive natural precursors in the production of chemicals with sustainable feedstocks,” said Andrey Zarur, Ph.D., Chairman and CEO, GreenLight Biosciences. “This unique partnership will couple the potential of our cell-free platform for efficient manufacturing with the remarkable innovations of Bayer CropScience, which has one of the most advanced research and development organizations in the world.”
“We also contribute to sustainability by continually improving our production and supply chain processes,” said Dr. Axel Trautwein, Head of Small Molecules Research at Bayer CropScience. “Collaborations with external research partners play a major role at Bayer CropScience. Working with GreenLight allows us to explore new possibilities to achieve this goal.”
Financial terms of the agreement between GreenLight Biosciences and Bayer CropScience were not disclosed.
About GreenLight Biosciences
GreenLight Biosciences is a privately-held biotechnology company focused on improving human health and the environment through the sustainable production of chemicals and fuels from renewable, non-petroleum based resources. Using its Unconstrained Metabolism® technology platform, which leverages proprietary breakthroughs in the production of cell-free biological processes, GreenLight discovers and develops clean, sustainable and economical chemicals. These chemicals serve as the basis for the creation of raw materials that have vast potential to increase access to healthier and more natural consumer products, primarily in nutrition, biopharmaceuticals, and agriculture, and in providing promising new energy options for our future. GreenLight Biosciences headquarters is located in Medford, MA. For more information, visit www.glbiosciences.com
About Bayer CropScience
Bayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech materials. Bayer CropScience, the subgroup of Bayer AG responsible for the agricultural business, has annual sales of EUR 8,383 million (2012) and is one of the world’s leading innovative crop science companies in the areas of seeds, crop protection and non-agricultural pest control. The company offers an outstanding range of products including high value seeds, innovative crop protection solutions based on chemical and biological modes of action as well as an extensive service backup for modern, sustainable agriculture. In the area of non-agricultural applications, Bayer CropScience has a broad portfolio of products and services to control pests from home and garden to forestry applications. The company has a global workforce of 20,800 and is represented in more than 120 countries.
Topics
Species
